Bloomberg has been hot on the trail of the Seroquel litigation, and in its latest foray into newly unsealed documents, found that AstraZeneca in 2002 warned Japanese doctors of diabetes cases in Seroquel patients "where causality with the drug could not be ruled out." Similar U.S. warnings did not come until 2004, the news service states. Report